Kazia Therapeutics Annual Report 2021

STATEMENT OF FINANCIAL POSITION As at 30 June 2021 38 Kazia Therapeutics Limited 38 Annual Report 2021 Consolidated Note 2021 2020 $ $ Assets Current assets Cash and cash equivalents 9 27,586,760 8,764,044 Trade and other receivables 10 84,362 1,352,252 Other assets 11 1,719,696 537,305 Total current assets 29,390,818 10,653,601 Non-current assets Trade and other receivables 10 6,693,628 - Intangibles 12 22,002,593 12,410,139 Total non-current assets 28,696,221 12,410,139 Total assets 58,087,039 23,063,740 Liabilities Current liabilities Trade and other payables 13 4,932,660 3,488,933 Employee benefits 14 229,337 191,451 Contingent consideration 15 3,164,557 1,387,089 Total current liabilities 8,326,554 5,067,473 Non-current liabilities Deferred tax 16 2,928,441 3,412,788 Employee benefits 14 54,684 - Contingent consideration 15 8,926,641 457,899 Total non-current liabilities 11,909,766 3,870,687 Total liabilities 20,236,320 8,938,160 Net assets 37,850,719 14,125,580 Equity Contributed equity 17 80,290,062 48,781,214 Other contributed equity 18 464,000 464,000 Reserves 19 1,300,566 1,065,923 Accumulated losses (44,203,909) (36,185,557) Total equity 37,850,719 14,125,580 The above statement of financial position should be read in conjunction with the accompanying notes

RkJQdWJsaXNoZXIy MjE2NDg3